NDC 0169-2035

SOGROYA

Somapacitan-beco

SOGROYA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Somapacitan.

Product ID0169-2035_c0e6a17e-40b0-4579-9d15-92816a0b63b2
NDC0169-2035
Product TypeHuman Prescription Drug
Proprietary NameSOGROYA
Generic NameSomapacitan-beco
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2021-06-15
Marketing CategoryBLA /
Application NumberBLA761156
Labeler NameNovo Nordisk
Substance NameSOMAPACITAN
Active Ingredient Strength3 mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0169-2035-11

1 SYRINGE, PLASTIC in 1 CARTON (0169-2035-11) > 1.5 mL in 1 SYRINGE, PLASTIC
Marketing Start Date2021-06-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "SOGROYA" or generic name "Somapacitan-beco"

NDCBrand NameGeneric Name
0169-2030SOGROYAsomapacitan-beco
0169-2035SOGROYAsomapacitan-beco

Trademark Results [SOGROYA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
SOGROYA
SOGROYA
79262550 5934737 Live/Registered
Novo Nordisk Health Care AG
2019-05-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.